NCT05200000 - Wharton's Jelly Eye Drops in the Treatment of Chronic Keratitis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 8, 2020

Primary Completion Date

June 20, 2023

Study Completion Date

June 20, 2023

Conditions

Keratitis, UlcerativeCorneal Ulcer

Interventions

BIOLOGICAL

SygeLIX-Coll-T

Reconstituted suspension made of Trehalose and chemically treated, grinded, freeze-dried and sterilized Wharton's Jelly used by the patient as eye drops.

Trial Locations (6)

34295

Hôpital Gui de Chauliac, CHU de Montpellier, Montpellier

38700

Hôpital Michallon, CHU de Grenoble, La Tronche

42270

Hôpital Nord, CHU de Saint-Etienne, Saint-Priest-en-Jarez

75012

Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris

75019

Hôpital Fondation Adolphe de Rothschild, Paris

76000

Hôpital Charles-Nicolle, CHU de Rouen, Rouen